Table 1 Baseline characteristics
From: Vascular Cell Adhesion Molecule 1 in atrial fibrillation
Serum (n = 146) | P Value | LAA Tissue (n = 34) | P value | |||
|---|---|---|---|---|---|---|
Stroke AF (n = 67) | Non-stroke AF (n = 79) | Stroke AF (n = 13) | Non-stroke AF (n = 21) | |||
Age (y) | 65.8 ± 7.7 | 65.0 ± 7.9 | .766 | 60.4 ± 9.8 | 54.0 ± 5.1 | .182 |
Sex (Female, n, %) | 21 (31.3) | 29 (36.7) | .836 | 3 (23.0) | 6 (28.5) | .089 |
BMI (kg/m2) | 25.5 ± 3.4 | 23.9 ± 3.0 | .157 | 23.7 ± 4.1 | 19.9 ± 11.5 | .328 |
Paroxysmal AF (n, %) | 29 (43.3) | 56 (70.8) | .010 | 6 (47.2) | 11 (52.3) | .316 |
LAD(cm) | 4.43 ± 0.80 | 3.95 ± 0.69 | .090 | 5.75 ± 1.29 | 4.71 ± 0.42 | .106 |
LVEF (%) | 59.5 ± 3.3 | 60.5 ± 3.0 | .377 | 52.6 ± 7.1 | 57.4 ± 8.3 | .258 |
Hypertension (n, %) | 37 (55.3) | 44 (55.6) | .957 | 8 (61.5) | 6 (28.3) | .021 |
Diabetes (n, %) | 7 (10.4) | 17 (21.5) | .233 | 2 (15.3) | 2 (9.5) | .486 |
Arteriosclerosis (n, %) | 36 (53.7) | 51 (65.2) | .582 | 8 (61.5) | 8 (38.0) | .035 |
Fibrinogen(ug/mL) | 1.9 ± 0.6 | 1.8 ± 0.7 | .069 | 1.7 ± 0.5 | 1.6 ± 0.6 | .071 |
D-Dimer(ug/mL) | 0.23 ± 0.21 | 0.18 ± 0.15 | .081 | 0.19 ± 0.20 | 0.14 ± 0.23 | .092 |
NT-proBNP(pg/mL) | 445 ± 169 | 387 ± 210 | .580 | 505 ± 113 | 441 ± 107 | .312 |
NYHA class ≥ 2 (n, %) | 30(44.8) | 43 (54.4) | .063 | 7(53.8) | 9(42.8) | .059 |